Brief: Mithra Pharmaceuticals End-Year Cash Position At 9.0 Mln Euros

Mithra Pharmaceuticals SA

08/03/2024 06:03

March 8 (Reuters) - Mithra Pharmaceuticals SA
 MITRA.BR :
    * MITHRA REPORTS FULL YEAR 2023 FINANCIAL RESULTS
    * FY REVENUES WERE EUR 40.2 MILLION, DOWN FROM 2022 RESULT
OF EUR
67.0 MILLION
    * CASH POSITION, AT EUR 9.0 MILLION AT END OF 2023, IS DOWN
COMPARED TO PREVIOUS YEAR (EUR 28.3 MILLION END 2022)
    * PRODUCT SALES WERE EUR 18.7 MILLION, UP +19.3% VERSUS EUR
15.7
MILLION IN 2022
    * ESTELLE PRODUCT SALES REACHED EUR 10.4 MILLION IN 2023
    * APPOINTMENT OF CHRISTOPHE MARÉCHAL AND XAVIER PAOLI AS
CO-CEOS
FOLLOWING TERMINATION OF MANAGEMENT AGREEMENT OF FORMER CEO

Source text: https://tinyurl.com/mryeumx5
Further company coverage:  MITRA.BR 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))